XEL Outpaces Peers Even as Analysts Trim Targets Before October 29 Print

Xcel Energy rose 2.7% over the past week to $76.68, beating the median gain of around 1.1% for its closest regulated utility peers, a notable reversal for a stock that had been lagging the group through much of the year.

Among the peer group, SO added 3.0% on the week and DUK gained 2.7%, broadly matching Xcel's pace. EVRG and OGE both trailed materially, up less than 1%. Xcel's own short interest picture has been the defining feature of the past few weeks: shorts jumped from roughly 41 million shares to just under 49 million in a single step around October 9 and have barely moved since, leaving SI at 8.3% of free float. That build, documented in last week's note, has not reversed. What has changed is the borrow market. Availability has loosened sharply, climbing to 1,532% from around 1,134% a week ago, meaning roughly fifteen shares are now available to lend for every one out on loan. That is the highest availability reading in the past year. Borrowing costs have also eased, falling to 0.47% from 0.56% a week earlier. The short position remains large by utility standards, but the lending market is moving in the opposite direction, becoming more accommodative rather than tighter.

The Street's direction this week has been a series of target cuts with ratings held. Morgan Stanley raised its target modestly to $85 from $83 while keeping an Equal-Weight rating, the one move against the grain. BMO Capital trimmed to $86 from $91, and earlier in the week Barclays cut to $85 from $90 and Keybanc to $87 from $90, both maintaining positive ratings. The consensus mean target is $88.61, implying roughly 16% above the current price. That gap is real but has been compressing as analysts recalibrate. Separately, Scotiabank initiated at Sector Outperform with a $77 target at the end of September, essentially flagging the stock at current levels. Factor positioning is split: Xcel ranks in the 95th percentile for dividend score and 97th for analyst recommendation differential, and its forward earnings growth estimate ranks in the 95th percentile. On valuation, it ranks 18th percentile on EV/EBIT, meaning it is not cheap on an earnings-to-capital basis. The PE has expanded roughly a point over the past 30 days to 17.2x as the stock has re-rated higher.

Options positioning is calm. The put/call ratio is 2.75, running just slightly below its 20-day average of 3.03, with a z-score of minus 0.21. The 52-week PCR range runs from 0.13 to 8.97, with the current reading in the lower half of that band. Hedging pressure is not building into earnings, which is a mild contrast to the short interest picture.

Institutional ownership data shows BlackRock added nearly 7 million shares in the quarter to September 30, taking its stake to 9.75% of shares. Capital Research added around 2 million shares over the same period. T. Rowe Price, by contrast, trimmed from 5.5% to 4.7% as of November last year per its 13G filing, a move worth noting though the disclosure is event-driven and the position may have changed further. No 13D activist is on the register.

Earnings are scheduled for October 29. The most recent print, in late July, produced a day-one move of minus 0.7% and a five-day drift of minus 2.3%. The short score has ticked down fractionally this week to 54.8 from 55.6, a small easing of short pressure but still well above levels seen before the October 9 step-change in SI. The level to watch is whether short interest begins to unwind ahead of the October 29 release or whether the 49 million share position holds into the print.